Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DEODATI

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
International Journal of Molecular Sciences|June 6, 2018
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian MeetingMaria Elisabeth Street, Sabrina Angelini, Sergio Bernasconi, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2020
Long-term mortality after childhood growth hormone treatment: the SAGhE cohort studyLars Sävendahl, Rosie Cooke, Anders Tidblad, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2018
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE CohortAnthony J Swerdlow, Rosie Cooke, Dominique Beckers, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2017
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort StudyAnthony J Swerdlow, Rosie Cooke, Dominique Beckers, et al.
Hormone Research in Paediatrics|August 1, 2015
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth HormoneAnthony J Swerdlow, Rosie Cooke, Kerstin Albertsson-Wikland, et al.
Frontiers in Immunology|September 12, 2022
Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case reportBiagio Di Lorenzo, Lucia Pacillo, Giulia Milardi, et al.
Frontiers in Genetics|December 26, 2024
Widening the infantile hypotonia with psychomotor retardation and characteristic Facies-1 Syndrome's clinical and molecular spectrum through NALCN <i>in-silico</i> structural analysisDavide Vecchio, Marina Macchiaiolo, Michaela V Gonfiantini, et al.
Plos One|May 11, 2021
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVIDJorge Calderón-Parra, Antonio Muiño-Miguez, Alejandro D Bendala-Estrada, et al.
Acta Diabetologica|May 18, 2026
Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study GroupBruno Bombaci, Marta Bassi, Valeria Castorani, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
International Journal of Molecular Sciences|June 6, 2018
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian MeetingMaria Elisabeth Street, Sabrina Angelini, Sergio Bernasconi, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2020
Long-term mortality after childhood growth hormone treatment: the SAGhE cohort studyLars Sävendahl, Rosie Cooke, Anders Tidblad, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2018
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE CohortAnthony J Swerdlow, Rosie Cooke, Dominique Beckers, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2017
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort StudyAnthony J Swerdlow, Rosie Cooke, Dominique Beckers, et al.
Hormone Research in Paediatrics|August 1, 2015
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth HormoneAnthony J Swerdlow, Rosie Cooke, Kerstin Albertsson-Wikland, et al.
Frontiers in Immunology|September 12, 2022
Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case reportBiagio Di Lorenzo, Lucia Pacillo, Giulia Milardi, et al.
Frontiers in Genetics|December 26, 2024
Widening the infantile hypotonia with psychomotor retardation and characteristic Facies-1 Syndrome's clinical and molecular spectrum through NALCN <i>in-silico</i> structural analysisDavide Vecchio, Marina Macchiaiolo, Michaela V Gonfiantini, et al.
Plos One|May 11, 2021
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVIDJorge Calderón-Parra, Antonio Muiño-Miguez, Alejandro D Bendala-Estrada, et al.
Acta Diabetologica|May 18, 2026
Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study GroupBruno Bombaci, Marta Bassi, Valeria Castorani, et al.
Pageof 9